Allina Health Cancer Institute - United Hospital — Saint Paul, Minnesota

Allina Health Cancer Institute - United Hospital is a clinical research site located in Saint Paul, Minnesota, United States 55102.

Crixeo Clinical Trials Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.

Allina Health Cancer Institute - United Hospital has participated in 5 clinical trials with 5 currently active.

Therapeutic areas: Breast Cancer, Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic.

Sponsors: Pfizer, Seagen, a wholly owned subsidiary of Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Saint Paul

Browse all research sites in Minnesota · View every site in Saint Paul

Sponsor Feasibility Report

Trust Score: 87/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Allina Health Cancer Institute - United Hospital?

Allina Health Cancer Institute - United Hospital has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Allina Health Cancer Institute - United Hospital conducted?

Allina Health Cancer Institute - United Hospital has 5 clinical trials on record, with 5 currently active. Their work covers Breast Cancer, Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic.

Is Allina Health Cancer Institute - United Hospital accredited by Crixeo Clinical Trials?

Allina Health Cancer Institute - United Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Allina Health Cancer Institute - United Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.